These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 30550256)

  • 1. Hacking the Brain: Dimensions of Cognitive Enhancement.
    Dresler M; Sandberg A; Bublitz C; Ohla K; Trenado C; Mroczko-Wąsowicz A; Kühn S; Repantis D
    ACS Chem Neurosci; 2019 Mar; 10(3):1137-1148. PubMed ID: 30550256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognition enhancers between treating and doping the mind.
    Lanni C; Lenzken SC; Pascale A; Del Vecchio I; Racchi M; Pistoia F; Govoni S
    Pharmacol Res; 2008 Mar; 57(3):196-213. PubMed ID: 18353672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs, games, and devices for enhancing cognition: implications for work and society.
    Brühl AB; Sahakian BJ
    Ann N Y Acad Sci; 2016 Apr; 1369(1):195-217. PubMed ID: 27043232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is neuroenhancement by noninvasive brain stimulation a net zero-sum proposition?
    Brem AK; Fried PJ; Horvath JC; Robertson EM; Pascual-Leone A
    Neuroimage; 2014 Jan; 85 Pt 3(0 3):1058-68. PubMed ID: 23880500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creativity on demand - Hacking into creative problem solving.
    Beda Z; Smith SM; Orr J
    Neuroimage; 2020 Aug; 216():116867. PubMed ID: 32325208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The likelihood of cognitive enhancement.
    Lynch G; Palmer LC; Gall CM
    Pharmacol Biochem Behav; 2011 Aug; 99(2):116-29. PubMed ID: 21215768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Closing thoughts for cognitive enhancement.
    Kantak KM; Wettstein JG
    Handb Exp Pharmacol; 2015; 228():451-9. PubMed ID: 25977093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive enhancement: promises and perils.
    Hyman SE
    Neuron; 2011 Feb; 69(4):595-8. PubMed ID: 21338872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doping for the brain].
    Iglseder B
    Z Gerontol Geriatr; 2018 Feb; 51(2):143-148. PubMed ID: 29209802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroenhancement and mood enhancement – Physiological and pharmacodynamical background.
    Weiergräber M; Ehninger D; Broich K
    Med Monatsschr Pharm; 2017 Apr; 40(4):154-64. PubMed ID: 29952165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacological Cognitive Enhancement: Current Situation and Perspectives].
    Yamamoto M
    Yakugaku Zasshi; 2022; 142(5):521-526. PubMed ID: 35491158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of neuroscience on society: cognitive enhancement in neuropsychiatric disorders and in healthy people.
    Sahakian BJ; Bruhl AB; Cook J; Killikelly C; Savulich G; Piercy T; Hafizi S; Perez J; Fernandez-Egea E; Suckling J; Jones PB
    Philos Trans R Soc Lond B Biol Sci; 2015 Sep; 370(1677):20140214. PubMed ID: 26240429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Should one use medications in combination with cognitive training? If so, which ones?
    Yesavage J; Hoblyn J; Friedman L; Mumenthaler M; Schneider B; O'Hara R
    J Gerontol B Psychol Sci Soc Sci; 2007 Jun; 62 Spec No 1():11-8. PubMed ID: 17565161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician attitudes towards pharmacological cognitive enhancement: safety concerns are paramount.
    Banjo OC; Nadler R; Reiner PB
    PLoS One; 2010 Dec; 5(12):e14322. PubMed ID: 21179461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of non-invasive brain stimulation on cognitive functioning in brain disorders: a meta-analysis.
    Begemann MJ; Brand BA; Ćurčić-Blake B; Aleman A; Sommer IE
    Psychol Med; 2020 Nov; 50(15):2465-2486. PubMed ID: 33070785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle use of drugs by healthy people for enhancing cognition, creativity, motivation and pleasure.
    d'Angelo LC; Savulich G; Sahakian BJ
    Br J Pharmacol; 2017 Oct; 174(19):3257-3267. PubMed ID: 28427114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyunsaturated fatty acids as putative cognitive enhancers.
    Yehuda S
    Med Hypotheses; 2012 Oct; 79(4):456-61. PubMed ID: 22800804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective and subjective cognitive enhancing effects of mixed amphetamine salts in healthy people.
    Ilieva I; Boland J; Farah MJ
    Neuropharmacology; 2013 Jan; 64():496-505. PubMed ID: 22884611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroethical issues in cognitive enhancement.
    Sahakian BJ; Morein-Zamir S
    J Psychopharmacol; 2011 Feb; 25(2):197-204. PubMed ID: 20212064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior.
    Racine E; Sattler S; Boehlen W
    Sci Eng Ethics; 2021 Mar; 27(2):19. PubMed ID: 33759032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.